Pfizer (PFE) P/B (1999 - 2026)
Pfizer (PFE) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Pfizer (PFE) P/B is 1.56. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Pfizer (PFE)
| Year | P/B | Change |
|---|---|---|
| 2026 | 1.56 | -4.50% |
| 2025 | 1.64 | -3.97% |
| 2024 | 1.70 | +1.65% |
| 2023 | 1.68 | -45.93% |
| 2022 | 3.10 | -27.71% |
| 2021 | 4.29 | +32.63% |
| 2020 | 3.23 | -0.91% |
| 2019 | 3.26 | -14.93% |
| 2018 | 3.84 | +14.03% |
| 2017 | 3.37 | +13.97% |
| 2016 | 2.95 | +1.17% |
| 2015 | 2.92 | +11.24% |
| 2014 | 2.62 | +4.69% |
| 2013 | 2.51 | +15.11% |
| 2012 | 2.18 | +22.90% |
| 2011 | 1.77 | +16.66% |
| 2010 | 1.52 | +5.94% |
| 2009 | 1.43 | -13.72% |
| 2008 | 1.66 | +21.97% |
| 2007 | 1.36 | -12.24% |
| 2006 | 1.55 | +11.06% |
| 2005 | 1.40 | -13.28% |
| 2004 | 1.61 | -23.89% |
| 2003 | 2.12 | +15.57% |
| 2002 | 1.83 | -23.29% |
| 2001 | 2.39 | -13.37% |
| 2000 | 2.76 | +41.80% |
| 1999 | 1.94 | N/A |
Comparison Pfizer (PFE) P/B with competitors
Pfizer (PFE) P/B is 1.56.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -56.25% |
| GRFS | Grifols SA | 0.79 | -49.46% |
| SNY | Sanofi | 1.27 | -18.76% |
| BIIB | Biogen Inc | 1.52 | -2.83% |
| OGN | Organon & Company | 3.93 | +151.14% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | +161.69% |
| GSK | GSK Plc | 4.37 | +179.67% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +286.37% |
| AZN | Astrazeneca plc | 6.20 | +296.60% |
| MRK | Merck & Co Inc | 6.68 | +327.31% |
| GILD | Gilead Sciences Inc | 6.94 | +343.94% |
| NVO | Novo Nordisk | 7.07 | +352.26% |
| NVS | Novartis AG | 7.60 | +386.16% |
| JNJ | Johnson & Johnson | 7.64 | +388.72% |
| NSRX | Nasus Pharma Ltd | 12.90 | +725.19% |
| MDCX | MDCorp | 15.34 | +881.28% |
| AMGN | AMGEN Inc | 21.17 | +1254.21% |
| SCLX | Scilex Holding Company | 28.85 | +1745.49% |
| LLY | Lilly(Eli) & Company | 32.94 | +2007.12% |
| ABBV | Abbvie Inc | 50.46 | +3127.85% |